Company Filing History:
Years Active: 2011-2013
Title: The Innovations of Marc Tessier-Lavigne
Introduction
Marc Tessier-Lavigne is a prominent inventor based in Woodside, CA (US). He has made significant contributions to the field of biotechnology, particularly in the areas of cancer treatment and neuronal regeneration. With a total of 2 patents, his work has had a profound impact on medical research and therapeutic development.
Latest Patents
One of his latest patents is focused on an anti-alpha5/beta1 antibody. This invention relates to the use of VEGF antagonists and alpha5beta1 antagonists for treating cancer and inhibiting angiogenesis and/or vascular permeability. It includes methods for inhibiting abnormal angiogenesis in various diseases. Additionally, this patent discusses the use of VEGFR agonists and alpha5beta1 agonists to promote angiogenesis and vascular permeability. It also introduces new anti-alpha5beta1 antibodies, compositions, kits, and methods for their application. Another significant patent by Tessier-Lavigne involves modulators of neuronal regeneration. This invention provides methods and compositions related to central nervous system (CNS) function and diseases.
Career Highlights
Marc Tessier-Lavigne has had a distinguished career, working at Genentech, Inc., where he has been able to apply his innovative ideas in a collaborative environment. His research has been pivotal in advancing our understanding of complex biological processes and developing new therapeutic strategies.
Collaborations
Throughout his career, Tessier-Lavigne has collaborated with notable colleagues, including Anan Chuntharapai and Gregory D Plowman. These partnerships have further enhanced the impact of his research and inventions.
Conclusion
Marc Tessier-Lavigne's contributions to biotechnology and medicine through his patents and research are invaluable. His work continues to inspire advancements in cancer treatment and neuronal regeneration, showcasing the importance of innovation in improving human health.